{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:21:09Z","timestamp":1794406869888,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jaad.2024.12.016","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:00:00Z","timestamp":1734577200000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The association between obesity and efficacy of psoriasis therapies: An expert consensus panel"],"prefix":"10.1016","volume":"92","author":[{"given":"Joshua","family":"Burshtein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"DeBusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Brad Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Stein","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Merola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosmarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaad.2024.12.016_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2021.06.883","article-title":"Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: a prospective analysis in Corrona Psoriasis Registry","volume":"86","author":"Enos","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib3","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaad.2018.12.037","article-title":"All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis","volume":"80","author":"Dhana","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002739","article-title":"Evidence of a causal relationship between body mass index and psoriasis: a Mendelian randomization study","volume":"16","author":"Budu-Aggrey","year":"2019","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.12.016_bib6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2017.03.037","article-title":"Real-world burden of comorbidities in US patients with psoriasis","volume":"77","author":"Shah","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"7","key":"10.1016\/j.jaad.2024.12.016_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamadermatol.2013.722","article-title":"Effect of weight loss on the severity of psoriasis: a randomized clinical study","volume":"149","author":"Jensen","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.12.016_bib11","first-page":"13","article-title":"Recommendations for initiating systemic therapy in patients with psoriasis","volume":"12","author":"Martin","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-023-00816-1","article-title":"Guselkumab-treated patients with plaque psoriasis who achieved complete skin clearance for \u2265 156 consecutive weeks: a post-hoc analysis from the VOYAGE 1 clinical trial","volume":"25","author":"Puig","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.12.016_bib15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40261-021-01080-z","article-title":"Impact of body mass index on the efficacy of biological therapies in patients with psoriasis: a real-world study","volume":"41","author":"Pirro","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000513398","article-title":"First-line biologic therapy and obesity in moderate-to-severe psoriasis: results from the prospective multicenter cohort PsoBioTeq","volume":"237","author":"Assan","year":"2021","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2024.12.016_bib17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with\u00a0systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/bjd.17738","article-title":"Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis","volume":"181","author":"Mourad","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.12.016_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000156599","article-title":"Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project","volume":"217","author":"Naldi","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2024.12.016_bib20","first-page":"1","article-title":"The effects of cardiometabolic comorbidities on biologic treatment for psoriasis with respect to PASI scores: a qualitative systematic review","volume":"14","author":"Osman","year":"2024","journal-title":"Psoriasis (Auckl)"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell","year":"2004","journal-title":"J Am Board Fam Pract"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib22","first-page":"10","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Practical Assess Res Eval"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.25251\/skin.3.5.1","article-title":"Appropriate use criteria for the integration of diagnostic and prognostic Gene expression profile assays into the management of cutaneous malignant melanoma: an expert panel consensus-based modified Delphi process assessment","volume":"3","author":"Berman","year":"2019","journal-title":"SKIN J Cutan Med"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13555-024-01099-y","article-title":"The efficacy and safety of bimekizumab for plaque psoriasis: an expert consensus panel","volume":"14","author":"Burshtein","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.25251\/skin.8.3.1","article-title":"The role of field cancerization in selecting therapies for actinic keratosis: an expert consensus panel","volume":"8","author":"Zakria","year":"2024","journal-title":"SKIN J Cutan Med"},{"issue":"6","key":"10.1016\/j.jaad.2024.12.016_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1517\/14712598.2014.900541","article-title":"The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial","volume":"14","author":"Al-Mutairi","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib27","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s12325-023-02467-4","article-title":"The effectiveness of guselkumab by BMI category among patients with moderate-to-severe plaque psoriasis in the CorEvitas Psoriasis Registry","volume":"40","author":"Armstrong","year":"2023","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13555-024-01123-1","article-title":"Response types and factors associated with response types to biologic therapies in patients with moderate-to-severe plaque psoriasis from two randomized clinical trials","volume":"14","author":"Egeberg","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"8","key":"10.1016\/j.jaad.2024.12.016_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/09546634.2019.1626973","article-title":"Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis","volume":"31","author":"Pinter","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.jaad.2024.12.016_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jdv.14252","article-title":"The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled phase 3 studies of patients with moderate-to-severe plaque psoriasis","volume":"31","author":"Reich","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.14552","volume":"175","author":"Zweegers","year":"2016","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.12.016_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.12.016_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jdv.12001","article-title":"Obesity, waist circumference, weight change and the risk of psoriasis in US women","volume":"27","author":"Kumar","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamadermatol.2014.324","article-title":"Excess adiposity preceding pediatric psoriasis","volume":"150","author":"Becker","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.12.016_bib36","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10654-018-0366-z","article-title":"Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies","volume":"33","author":"Aune","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"15","key":"10.1016\/j.jaad.2024.12.016_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","article-title":"Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses\u2019 Health Study II","volume":"167","author":"Setty","year":"2007","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jaad.2024.12.016_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jaad.2024.12.016_bib39","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jid.2017.07.822","article-title":"Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study","volume":"137","author":"Snekvik","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","article-title":"Comorbidities associated with psoriasis: an experience from the Middle East","volume":"37","author":"Al-Mutairi","year":"2010","journal-title":"J Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.jaad.2024.12.016_bib43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.12.016_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2024.12.016_bib45","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jaad.2024.12.016_bib47","first-page":"864","article-title":"Efficacy of adalimumab compared with methotrexate or placebo stratified by baseline BMI in a randomized placebo-controlled trial in patients with psoriasis","volume":"14","author":"Prussick","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.12.016_bib48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjd.20971","article-title":"Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial","volume":"186","author":"Augustin","year":"2022","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archderm.1971.04000150020003","article-title":"Hepatotoxicity of methotrexate in the treatment of psoriasis","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2024.12.016_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archderm.1989.01670210047006","article-title":"Detection of hepatotoxicity associated with methotrexate therapy for psoriasis","volume":"125","author":"O\u2019Connor","year":"1989","journal-title":"Arch Dermatol"},{"issue":"10S","key":"10.1016\/j.jaad.2024.12.016_bib51","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0000955584.31466.98","article-title":"S1486 impact of obesity on liver fibrosis and steatosis in patients diagnosed with methotrexate-associated liver injury: a retrospective study","volume":"118","author":"Mahmoud","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","article-title":"Methotrexate hepatotoxicity and the impact of nonalcoholic fatty liver disease","volume":"354","author":"Shetty","year":"2017","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12875","article-title":"Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice","volume":"32","author":"Hong","year":"2019","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2023.07.635","article-title":"43250 Efficacy of apremilast in patients with moderate-to-severe plaque psoriasis across weight and BMI subgroups: analysis from ESTEEM 1 and ESTEEM 2","volume":"89","author":"Langley","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2024.12.016_bib55","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3846","article-title":"Effectiveness of apremilast in real life in patients with psoriasis: a longitudinal study","volume":"101","author":"Malara","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2024.12.016_bib56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jdv.14598","article-title":"Apremilast in psoriasis \u2013 a prospective real-world study","volume":"32","author":"Vujic","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.12.016_bib57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jdin.2024.02.016","article-title":"Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world setting","volume":"16","author":"Cavanaugh","year":"2024","journal-title":"JAAD Int"},{"issue":"3","key":"10.1016\/j.jaad.2024.12.016_bib58","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/rheumatology\/keab474","article-title":"Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study","volume":"61","author":"Ferguson","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2024.12.016_bib59","article-title":"Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy by prespecified baseline demographics in the phase 3 POETYK PSO-1 and POETYK PSO-2 trials","author":"Gooderham","year":"2021","journal-title":"Eur Acad Dermatol Venereol 30th Anniv Congr"},{"issue":"11","key":"10.1016\/j.jaad.2024.12.016_bib60","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/medicina59112006","article-title":"An observational study of 147 psoriasis patients: overweightness and obesity as a significant clinical factors correlated with psoriasis","volume":"59","author":"Czarnecka","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jaad.2024.12.016_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34293-y","article-title":"Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jaad.2024.12.016_bib62","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.jaad.2024.12.016_bib63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","article-title":"Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery","volume":"152","author":"Egeberg","year":"2017","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.jaad.2024.12.016_bib64","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3825","article-title":"Impact of bariatric surgery on moderate to severe psoriasis: a retrospective nationwide registry study","volume":"101","author":"Laskowski","year":"2021","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224033905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224033905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:12:05Z","timestamp":1742343125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224033905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0190962224033905"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between obesity and efficacy of psoriasis therapies: An expert consensus panel","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}